Medline makes Nasdaq debut, Procter & Gamble upgraded to Buy
Affected assets and topics
Why it matters
Medline has successfully debuted on the Nasdaq at $35 per share, marking a significant public offering for 2025. Additionally, Procter & Gamble received an upgrade to 'Buy' from Jefferies, indicating positive sentiment towards the company's stock.
Article tone
Expected market reaction
Market impact analysis based on bullish sentiment with 78% confidence.
Evidence trail
Evidence
AI provenance
Technical identifiers
- Provider tag
- openai-gpt-4o-mini
- Analysis version
- openai-gpt-4o-mini
- Article id
- 23682
Original source
Yahoo Finance anchor Josh Lipton tracks Wednesday's top moving stocks and biggest market stories in this Market Minute. Medical supply company Medline (MDLN) made its debut on the Nasdaq Composite (^IXIC) at $35 per share, the biggest public offering of 2025. Procter & Gamble (PG) was upgraded to Buy from Hold by Jefferies. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.
Read the full article on Yahoo Finance
Original article published by Yahoo Finance on December 17, 2025. Analysis and insights provided by AnalystMarkets AI.